Key Highlights
- ARK Invest acquired 85,485 shares of Palantir totaling approximately $11.15M distributed across five ETFs
- The firm divested 44,446 AMD shares valued at roughly $10.52M, scaling back semiconductor holdings
- Palantir shares declined approximately 2% Friday following a sharp 7% drop the previous day
- “Big Short” investor Michael Burry flagged Palantir as overvalued, pointing to Anthropic’s competitive threat
- Wedbush analyst Daniel Ives rejected Burry’s concerns, reaffirming a Buy stance with $230 target price
Cathie Wood’s investment firm ARK Invest executed significant portfolio adjustments between April 10 and 11, 2026. The moves included accumulating Palantir Technologies shares while simultaneously divesting its Advanced Micro Devices holdings, based on official daily trading disclosures.
The investment firm secured 85,485 Palantir shares valued at roughly $11.15 million. Distribution occurred across five separate exchange-traded funds: ARKK acquired 46,455 shares, ARKQ obtained 15,127, ARKW picked up 11,865, ARKF added 5,973, and ARKX secured 6,065.
Palantir Technologies Inc., PLTR
Concurrently, the firm liquidated 44,446 shares of Advanced Micro Devices, representing approximately $10.52 million in total value. These sales were similarly spread across the identical five fund vehicles.
The strategic repositioning indicates ARK’s preference for AI software infrastructure over semiconductor manufacturing assets.
Turbulent Week for Palantir
Palantir’s stock experienced significant volatility during the period preceding ARK’s acquisition. Shares declined about 2% Friday after experiencing a more substantial 7% downturn Thursday.
The selloff gained momentum after Michael Burry, the investor famous for predicting the 2008 financial crisis, issued a warning via social media platform X. Burry characterized Palantir’s current market valuation as reflecting “bubble” characteristics.
His critique centered on Anthropic, the artificial intelligence company, which he believes is capturing market share from Palantir through its recently launched “Mythos” model and aggressive expansion. Cathie Wood capitalized on the price weakness to add exposure.
ARK additionally disposed of 75,389 shares in Strata Critical Medical valued at $305,325, extending a multi-day pattern of reducing that position.
Wall Street Split on Outlook
Burry’s bearish perspective hasn’t achieved universal acceptance among market watchers. Daniel Ives from Wedbush Securities dismissed Burry’s analysis as fundamentally flawed storytelling.
Ives maintained his bullish Buy recommendation on Palantir alongside a $230 price objective. He highlighted the company’s impressive 137% expansion in U.S. Commercial segment revenue as proof that competitive dynamics remain favorable.
Benchmark analyst Yi Fu Lee takes a more measured stance. Lee suggests that Palantir’s premium valuation creates pressure for continued strong operational performance to support current share prices.
Overall Wall Street sentiment leans toward Moderate Buy territory. The consensus reflects 14 Buy recommendations, 5 Hold positions, and 2 Sell ratings.
The mean analyst price target following the recent market turbulence stands at $194.61, implying approximately 52% potential appreciation from Friday’s market close.
Advanced Micro Devices shares advanced 3.55% on the same trading session that ARK exited its stake.
